3D Medicines Inc. (1244.HK)

HKD 3.98

(-4.33%)

Revenue Summary of 3D Medicines Inc.

  • 3D Medicines Inc.'s latest annual revenue in 2023 was 634.94 Million CNY , up 11.91% from previous year.
  • 3D Medicines Inc.'s latest quarterly revenue in 2024 Q2 was 103.21 Million CNY , down 0.0% from previous quarter.
  • 3D Medicines Inc. reported a annual revenue of 567.39 Million CNY in annual revenue 2022, up 841.57% from previous year.
  • 3D Medicines Inc. reported a annual revenue of 60.26 Million CNY in annual revenue 2021, down 0.0% from previous year.
  • 3D Medicines Inc. reported a quarterly revenue of 103.21 Million CNY for 2024 Q2, down 0.0% from previous quarter.
  • 3D Medicines Inc. reported a quarterly revenue of 176.27 Million CNY for 2023 Q2, down 0.0% from previous quarter.

Annual Revenue Chart of 3D Medicines Inc. (2023 - 2020)

Historical Annual Revenue of 3D Medicines Inc. (2023 - 2020)

Year Revenue Revenue Growth
2023 634.94 Million CNY 11.91%
2022 567.39 Million CNY 841.57%
2021 60.26 Million CNY 0.0%
2020 - CNY 0.0%

Peer Revenue Comparison of 3D Medicines Inc.

Name Revenue Revenue Difference
Uni-Bio Science Group Limited 484.71 Million HKD -30.993%
CK Life Sciences Int'l., (Holdings) Inc. 5.32 Billion HKD 88.071%